What are the sensitivity and specificity of Coronary Computed Tomography Angiography (CCTA) for diagnosing coronary artery disease in patients with intermediate pre-test probability of disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnostic Performance of CCTA for Coronary Artery Disease

CCTA demonstrates excellent sensitivity (95-99%) for detecting obstructive coronary artery disease but moderate specificity (64-83%), making it highly reliable for ruling out disease but less reliable for confirming stenosis severity. 1

Sensitivity and Specificity by Analysis Level

Per-Patient Analysis

  • Sensitivity: 95-99% for detecting ≥50% stenosis 1, 2
  • Specificity: 64-83% depending on patient population and calcification burden 1, 2
  • Positive Predictive Value (PPV): 64-86%, indicating moderate reliability for confirming disease 1, 3
  • Negative Predictive Value (NPV): 94-99%, making CCTA excellent for excluding significant CAD 1, 2, 4

The CCTA ACCURACY trial specifically reported 95% sensitivity, 83% specificity, 64% PPV, and 99% NPV for detection of CAD at the 50% stenosis threshold. 1

Per-Vessel Analysis

  • Sensitivity: 85-88% 1, 3
  • Specificity: 82-90% 1, 3
  • PPV: 47% (lower due to overestimation of stenosis) 3
  • NPV: 99% 3

Per-Segment Analysis

  • Sensitivity: 86-88% 1, 3
  • Specificity: 90-96% 1, 3
  • NPV: 96.5-99% 1, 3

Performance in Women vs Men

CCTA demonstrates similar diagnostic accuracy in women compared to men, with no significant sex-based differences in sensitivity or specificity. 2

  • Women: Sensitivity 90-93%, Specificity 77-88% 2
  • The specificity of any detectable coronary calcium (CAC >0) is significantly better in women (40-66%) than men (23-36%) 2
  • Women in these cohorts tend to be older with lower prevalence of obstructive CAD 2

Factors That Reduce Diagnostic Accuracy

Heavy Coronary Calcification

  • Significantly reduces specificity to as low as 32% at per-patient level 1, 4
  • Causes overestimation of stenosis severity 4, 5
  • Limits accurate assessment of plaque composition 4

Technical and Patient Factors

  • High or irregular heart rates cause motion artifacts that falsely suggest stenosis 4, 5
  • Obesity and poor body habitus reduce image quality 4
  • Small vessels (<1.5-3.0mm) are difficult to assess accurately 4, 5
  • In-stent restenosis evaluation has lower accuracy, particularly for stents <3.0mm diameter 5

Comparison with FFR-CT

Adding FFR-CT to CCTA significantly improves specificity while maintaining high sensitivity, addressing CCTA's main limitation of overestimating stenosis. 1

FFR-CT Performance

  • Sensitivity: 85-93% (similar to CCTA alone) 1
  • Specificity: 65-82% (significantly higher than CCTA's 32-46%) 1
  • Overall accuracy: 84% vs 59% for CCTA alone 1
  • FFR-CT correctly reclassified 68% of false-positive CCTA results as true negatives 1

Per-Patient vs Per-Vessel FFR-CT Analysis

  • Per-patient: Sensitivity 89%, Specificity 71% 1
  • Per-vessel: Sensitivity 85%, Specificity 82% 1

Clinical Context and Pre-Test Probability

In patients with high pre-test probability of CAD (67%), CCTA demonstrates PPV of 82.7% and NPV of 85.0%, with diagnostic performance not influenced by angina type. 1

The CORE-64 study reported a receiver operating characteristic (ROC) area of 0.93 for CCTA using quantitative coronary angiography as reference standard. 1

Common Pitfalls to Avoid

  • Do not rely on CCTA alone for quantifying stenosis severity in intermediate lesions—functional testing or FFR-CT is needed 1, 5
  • Recognize that positive CCTA often overestimates obstruction severity and requires further testing to guide management 3
  • Avoid CCTA in patients with extensive calcification, irregular heart rates, or significant obesity where image quality will be inadequate 6
  • Remember that anatomic stenosis does not always correlate with hemodynamic significance—functional assessment may be needed 5

Prognostic Value Beyond Diagnosis

CCTA provides prognostic information beyond stenosis detection, with presence of non-obstructive CAD and high-risk plaque features predicting adverse cardiovascular events. 1, 4

  • Patients with extensive non-obstructive CAD have higher adverse event rates (14.5%) than those with less extensive but obstructive disease (13.6%) 1
  • Absence of atherosclerosis on CCTA is associated with very favorable prognosis 1
  • High-risk plaque features are independent predictors of major acute coronary events even in non-obstructive CAD 1

References

Guideline

Role of Coronary CT Angiography in Diagnosing Coronary Artery Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Capabilities of Chest CT Angiography

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

CT Coronary Angiogram: Diagnostic Capabilities and Clinical Applications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

How is coronary computed tomography angiography (CCTA) performed in a patient with left bundle‑branch block and frequent premature ventricular contractions, ensuring appropriate heart‑rate control and contrast safety?
What type of CT scan is needed for CABG evaluation?
What are the indications and contraindications for coronary CT angiography in adult patients?
Which measurement is more accurate for ascending aorta diameter, EKG (electrocardiogram)-gated CT (computed tomography) angiogram or TTE (transthoracic echocardiogram)?
What is the appropriate workup for a positive computed tomography angiography (CTA) result?
What is the recommended frequency for stress testing in a patient with a history of coronary artery disease or other underlying heart conditions taking flecainide (anti-arrhythmic medication)?
How often does a patient without coronary artery disease (CAD), who has undergone a cardiac catheterization and is taking flecainide (flecainide) for arrhythmia management, need a stress test?
What could be the cause of large blood clots coming from the rectum in a patient, considering their age, medical history, including previous gastrointestinal issues or surgeries, and current medications, especially anticoagulants?
What does an Alanine Transaminase (ALT) level of 9 U/L indicate?
What is the recommended time interval to administer Measles, Mumps, and Rubella (MMR) and Varicella vaccines after administering the Hepatitis B (HepB) vaccine today?
Should I increase the dose of Armour Thyroid (thyroid hormone replacement therapy) with a Thyroid-Stimulating Hormone (TSH) level of 0.45, which is at the lower end of the normal range?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.